| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8962215 | Radiotherapy and Oncology | 2018 | 7 Pages |
Abstract
Approximately 56% of patients who die of NSCLC in Ontario need PRT, but many are never treated.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Chunzi Jenny Jin, Weidong Kong, William J. Mackillop,